Skip to content
NEWSnet Waco
    • Homepage
Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in CRSwNP in Significant Majority of Participants Treated with Verekitug in the Phase 2 VIBRANT Trial at EAACI 2026

Category: Globe Newswire

Posted Date:

June 14, 2026
  • Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in CRSwNP in Significant Majority of Participants Treated with Verekitug in the Phase 2 VIBRANT Trial at EAACI 2026

    Upstream Bio
    June 14, 2026
  • Bitcoin Meets AI Trading: AIXAlpha Launches Free AI Strategy Contracts with Daily Settlement

    AixAlpha
    June 14, 2026
  • Ruvi AI (RUVI) Announces Phase 3 Has Reached 90% Sellout as Investors Race to Secure Remaining Tokens at $0.02

    Ruvi
    June 14, 2026
  • MUSSO E80 Muse Sees Strong U.S. Sales Following European Breakout and MUSE Design Award Win

    Musso Distribution GmbH
    June 14, 2026
  • Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

    Legend Biotech USA Inc.
    June 14, 2026
  • Salomon Unfolds the Next Chapter of ROAD TO THE FUTURE in Shanghai

    Salomon
    June 14, 2026
  • Rally House Ready with New York Knicks Championship Gear Following NBA Finals Victory

    Rally House
    June 13, 2026
  • NNOX Investors Have Opportunity to Lead Nano-X Imaging Ltd. Securities Fraud Lawsuit with the Schall Law Firm

    Schall Law
    June 13, 2026
  • MSFT Investors Have Opportunity to Lead Microsoft Corporation Securities Fraud Lawsuit with the Schall Law Firm

    Schall Law
    June 13, 2026
  • First-Ever Edie Harper Tile Collection Debuts at Motawi Tileworks

    MOTAWI TILEWORKS
    June 13, 2026
Prev
1 … 405 406 407